Healthcare provider profile · identity verified

Eugene Choi, M.D.

Internal Medicine · PANORAMA CITY, CA · NPI 1710340708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	939	331
Losartan Potassium	Losartan Potassium	623	221
Amlodipine Besylate	Amlodipine Besylate	484	182
Rosuvastatin Calcium	Rosuvastatin Calcium	451	173
Levothyroxine Sodium	Levothyroxine Sodium	317	103
Metformin Hcl	Metformin Hcl	311	111
Omeprazole	Omeprazole	294	120
Lisinopril	Lisinopril	281	102
Terazosin Hcl	Terazosin Hcl	213	71
Glipizide	Glipizide	203	75
Jardiance	Empagliflozin	194	66
Tamsulosin Hcl	Tamsulosin Hcl	168	68
Pantoprazole Sodium	Pantoprazole Sodium	157	58
Potassium Chloride	Potassium Chloride	150	57
Atenolol	Atenolol	143	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	139	36
Furosemide	Furosemide	138	57
Metformin Hcl Er	Metformin Hcl	136	51
Breyna	Budesonide/Formoterol Fumarate	128	63
Metoprolol Tartrate	Metoprolol Tartrate	127	49
Hydrochlorothiazide	Hydrochlorothiazide	125	50
Alendronate Sodium	Alendronate Sodium	122	43
Finasteride	Finasteride	122	40
Gabapentin	Gabapentin	121	45
Allopurinol	Allopurinol	112	39
Pradaxa	Dabigatran Etexilate Mesylate	112	40
Carvedilol	Carvedilol	111	41
Fluticasone Propionate	Fluticasone Propionate	106	33
Simvastatin	Simvastatin	106	40
Humulin N	Insulin Nph Human Isophane	83	29
Sertraline Hcl	Sertraline Hcl	81	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	33
Humulin N Kwikpen	Insulin Nph Human Isophane	77	20
Albuterol Sulfate Hfa	Albuterol Sulfate	74	42
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	72	27
Spiriva Respimat	Tiotropium Bromide	71	21
Clopidogrel	Clopidogrel Bisulfate	68	22
Pravastatin Sodium	Pravastatin Sodium	68	21
Duloxetine Hcl	Duloxetine Hcl	67	26
Fenofibrate	Fenofibrate	64	20
Meloxicam	Meloxicam	63	28
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	62	24
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	62	25
Trazodone Hcl	Trazodone Hcl	59	30
Mirtazapine	Mirtazapine	58	29
Triamcinolone Acetonide	Triamcinolone Acetonide	57	38
Ezetimibe	Ezetimibe	54	16
Spironolactone	Spironolactone	54	23
Latanoprost	Latanoprost	49	11
Fluoxetine Hcl	Fluoxetine Hcl	48	15
Lorazepam	Lorazepam	44	14
Hydralazine Hcl	Hydralazine Hcl	41	18
Alvesco	Ciclesonide	39	18
Hydrocortisone	Hydrocortisone	39	20
Tramadol Hcl	Tramadol Hcl	38	12
Bisoprolol Fumarate	Bisoprolol Fumarate	37	16
Eliquis	Apixaban	36	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Ibuprofen	Ibuprofen	33	20
Wixela Inhub	Fluticasone Propion/Salmeterol	33	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	29	29
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	29	13
Humulin R	Insulin Regular, Human	27	13
Ozempic	Semaglutide	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Colchicine	Colchicine	26	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	24
Buspirone Hcl	Buspirone Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	11
Montelukast Sodium	Montelukast Sodium	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	21	11
Humalog	Insulin Lispro	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Terbinafine Hcl	Terbinafine Hcl	20	16
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Metronidazole	Metronidazole	19	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	11
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Cefadroxil	Cefadroxil	16	16
Fluocinonide	Fluocinonide	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Prednisone	Prednisone	15	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Bupropion Xl	Bupropion Hcl	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Valsartan	Valsartan	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Cartia Xt	Diltiazem Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	12	11
Labetalol Hcl	Labetalol Hcl	12	suppressed
Metoprolol Succinate	Metoprolol Succinate	12	suppressed
Mupirocin	Mupirocin	12	11
Naproxen	Naproxen	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Victoza 2-Pak	Liraglutide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	11
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Famotidine	Famotidine	11	suppressed
Retin-A	Tretinoin	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error